Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s): QNTM

Healthcare

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

CSE:QNTM - Post by User

Quantum BioPharma Ltd > HUGE Reset

<< Previous

Bullboard Posts

Next >>

Comment by Mil_Man54on Oct 02, 2021 11:01pm

58 Views

Post# 33958241

RE:HUGE Reset

Through further dilution of shares on the backs of investors.....their next step was for the CEO, AD, to hire 6 marketing firms at a cost of $2.5M annually plus 219936 shares to hype FSD with nothing to hype......now they have to hire an entire team to even think of beginning any development let alone trials........why aren't you adding this info Rosenberg......it's is relevant and actually factual.....